Related Experiment Video
Updated: Sep 30, 2025
08:42
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
11.3K
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Aicha Kriaa1, Vincent Mariaule1, Amin Jablaoui1
1Microbiota Interaction with Human and Animal Team (MIHA), Micalis Institute, AgroParisTech, Université Paris-Saclay, INRAE, 78350 Jouy-en-Josas, France.
Cells
|March 10, 2022
Summary
Inflammatory bowel diseases (IBD) involve gut microbiota and bile acids (BAs). Understanding the gut microbiota-BA-host axis is crucial for developing new IBD treatments and managing digestive inflammation.
Area of Science:
- Gastroenterology and immunology
- Microbiome research
- Metabolomics
Background:
- Inflammatory bowel diseases (IBD) represent a growing global health concern with limited effective treatments.
- Gut microbiota dysbiosis is a known factor in IBD pathogenesis, affecting intestinal immunity.
- Bile acids (BAs) also play a significant role in maintaining gut homeostasis and disease development.
Purpose of the Study:
- To review the complex interactions between bile acids (BAs) and gut microbiota in the context of IBD.
- To elucidate the role of the gut microbiota-BA-host axis in the pathogenesis of digestive inflammation.
Main Methods:
- Literature review of existing studies on IBD, gut microbiota, and bile acid metabolism.
- Analysis of the interplay between microbial metabolites and host immune responses in IBD.
- Exploration of the gut microbiota-bile acid-host axis.
Main Results:
- Alterations in gut microbiota composition are intrinsically linked to dysregulated intestinal immunity in IBD.
- Bile acid profiles are significantly modified in IBD patients, impacting gut homeostasis.
- The gut microbiota actively modifies bile acids, influencing host-microbial interactions.
Conclusions:
- The gut microbiota-BA-host axis is a critical factor in the development and progression of IBD.
- Targeting the gut microbiota and bile acid metabolism offers potential therapeutic strategies for IBD.
- Further research into this axis may lead to novel treatments for digestive inflammation.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
217
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
217
01:29Drugs for Treatment of Ulcerative Colitis in IBD
256
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
256
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
249
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
01:17Chronic Bowel Disorders: Introduction
552
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
552
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
390
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
390
01:30Inflammatory Bowel Disease II: Crohn's Disease
434
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
434